Targeting NK Cell Inhibitory Receptors for Precision Multiple Myeloma Immunotherapy.

ABSTRACT: Innate immune surveillance of cancer involves multiple types of immune cells including the innate lymphoid cells (ILCs). Natural killer (NK) cells are considered the most active ILC subset for tumor elimination because of their ability to target infected and malignant cells without prior sensitization. NK cells are equipped with an array of activating and inhibitory receptors (IRs); hence NK cell activity is controlled by balanced signals between the activating and IRs. Multiple myeloma (MM) is a hematological malignancy that is known for its altered immune landscape. Despite improvements in therapeutic options for MM, this disease remains incurable. An emerging trend to improve clinical outcomes in MM involves harnessing the inherent ability of NK cells to kill malignant cells by recruiti

SUBMITTER: Alfarra H 

PROVIDER: S-EPMC7693637 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature